Chris Evelo (ELIXIR Netherlands) is the new co-leader of the ELIXIR Interoperability Platform, replacing Barend Mons, the Head of Dutch ELIXIR Node. Evelo joins Helen Parkinson (EMBL-EBI) and Carole Goble (ELIXIR UK) in leading the Interoperability Platform.
Six UM researchers will each receive up to...
On 12 May 2016 William Bull successfully defended his PhD-thesis on Optional Instruments of the European Union. A commercial edition of the thesis was published with Intersentia Publishers.
Maurice Zeegers has been Scientific Director of the CAPHRI School for Public Health and Primary Care for six months now: “This is an organisation with motivated and very talented researchers.”
In the InSciTe posture project (Projectleader Dr Paul Willems) the radiopaque UHMWPE technology (which is now FDA approved) will be tested in clinical patients for the final assessment of safety and efficacy.
'The patient as a partner, the patient as a co-producer in healthcare, the patient as a decision maker: self-management and ownership are common terms in healthcare policy. Many people are simply incapable of managing their own health in a proactive way.
The ‘Maastricht Study’, launched in 2010, reveals that the number of people in the preliminary phase of diabetes is much higher than initially thought: roughly a million people in the Netherlands alone.
Cinderella Therapeutics Foundation and Maastricht University's User Research Center (URC) jointly developed so-called tapering strips to slowly and safely taper off drug doses. Some health insurers, however, are refusing to cover the cost of these strips in their basic health insurance policies.
Tuna de Maastricht serenaded residents of the nursing home Zeven Bronnen today on behalf of Maastricht University, which is celebrating its 2016 anniversary year.